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www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMBackground: Women more often incur access site bleeding complications after
cardiac catheterization compared to men. Vascular closure devices have been intro-
duced into clinical practice with the aim of increasing procedural efﬁcacy and safety of
coronary angiography. Thus, vascular closure devices might be especially useful in
women. The gender-speciﬁc value of vascular closure devices versus manual
compression has not been assessed prospectively.
Methods: The Instrumental Sealing of ARterial puncture site – CLOSURE device
versus manual compression (ISAR-CLOSURE) study is a multicenter, randomized,
open-label clinical trial comparing FemoSeal, Exoseal and manual compression for
arteriotomy closure in patients undergoing coronary angiography via the common
femoral artery (random sequence 1:1:1). Primary endpoint is access site related
vascular complications, i.e. the composite of hematoma  5cm, pseudoaneurysm,
arteriovenous ﬁstula, access site related bleeding, acute ipsilateral limb ischemia, need
for vascular surgery/interventional treatment or local infarction at 30 days after ran-
domisation. This analysis will focus on gender speciﬁc aspects of the comparison of
arteriotomy closure with two different vascular closure devices versus manual
compression. A second comparison will be performed between the two vascular
closure devices. Outcomes examined will be stratiﬁed by gender. The trial is registered
with ClinicalTrials.gov Identiﬁer NCT01389375.
Results: From April 2011 until Mai 2014 a total of 4,524 patients have been enrolled
in the ISAR-CLOSURE trial, among them 1,395 women. The present analysis will be
gender-speciﬁc and will be available in August 2014. On the other hand, the primary
results of the trial will also be submitted as late breaking clinical trial at this year TCT
meeting.
Conclusions: The trial will help to assess the gender-speciﬁc role of two vascular
closure devices versus manual compression in patients undergoing cardiac catheteri-
zation via the common femoral artery.
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Background: The comparative effectiveness of bleeding avoidance strategies (BAS)
in reducing access site hematomas (ASH) after peripheral vascular interventions (PVI)
remains unclear.
Methods: 34,616 PVI from more than 100 centers included in the Vascular Quality
Initiative (VQI) Registry were analyzed. Preprocedural risk for ASH was predicted by
a model previously developed and validated based on data from the VQI registry.
Results: ASH complicated 1,116 procedures (3.22%). ASH rates differed by predicted
preprocedural risk (low risk 1.81%; moderate risk 3.13%; high risk 5.16%). Manual
compression (MC), bivalirudin, vascular closure device (VCD) and dual bleeding
avoidance strategy (BAS) with bivalirudin plus VCD were used in 33%, 5%, 30% and
3% of patients, respectively. Overall, ASH was less frequent in patients who received
VCD (2.51%, p< 0.001) and dual BAS (1.32%,p< 0.001) compared to patients who
had MC alone (3.98%), but of similar frequency in patients receiving bivalirudin alone
(3.46%, p¼0.295). Patients at high predicted risk had the greatest risk reduction (RR)
from the use of VCD (RR 0.548, 95% CI 0.417- 0.721; p < 0.001) and from dual BAS
(RR 0.235, 95% CI 0.059- 0.938; p< 0.040), however they were less likely to receive
VCD (39% vs. 45% in low risk and 44% in moderate-risk groups, p< 0.001).
Conclusions: VCD use, especially in conjunction with bivalirudin, was associated
with lower ASH rates among patients at moderate and high preprocedural risk;
however, high risk patients were less likely to receive VCD. Bivalirudin used alone
was not associated with lower ASH rates.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/VasculTCT-842
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Background: We report our single center experience using closure devices in
different types of endovascular interventions, using various and eventually multiple
access sites, between October/2012 and December/2013 in order to investigate their
safety and effectiveness, and to identify trigger decision-making features helping to
guide their use.
Methods: A retrospective analysis of consecutively treated patients in our department
was performed. Demographic, clinical/periprocedural ,post-operative data, complica-
tions and re-interventions due to the use of closure devices were analyzed. Puncture
site was routinely checked with Duplex ultrasound 24 h after operation and under
clinical suspicion.
Results: 2393(1409(72,2%) men; 543(27,8%) women) patients were included.
Among 3206 closure devices used, Perclose Proglide(Abbott Vascular, CA,USA)
was employed 2806 times(87,52%), Angio-SealTM(St. Jude Medical Inc.,MN,USA)
298(9,3%) and 102(3,18%) Exoseal(Cordis,NJ,USA). More than one type was used
in 55 patients(2,4%). Patients were 7011 years old. Vascular access sites (1.845
retrograde(77,1%), 548 antegrade(22,9%)) with sheath size ranging from 5F to 24F.
The overall success rate was 95,3% and did not signiﬁcantly vary according to the
device used(p< 0,05). Mild calciﬁcation was signiﬁcantly unfavorable to Proglide’s
use when compared to Angioseal(p< 0,05). Severe calciﬁcation related to unsuc-
cessful use of closures devices. High puncture site were prone to more signiﬁcant
bleeding complications, with no statistical difference among the devices, whereas low
punctures were more prone to occlusive complications, with a lower incidence among
proglide patients(p>0,05). Major complications occurred in 10 patients(0,5%).
Morbid obesity, previous anticoagulation, mild/severe calciﬁcation, dislodge puncture
site and 9F sheath resulted in higher complication risk.
Conclusions: Closure devices were safe and effective in this study. Higher compli-
cation rates were related with important vessel calciﬁcation, larger sheaths and
dislodged puncture sites. Further prospective randomized studies should be
performed.TCT-843
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Background: Haemmoragic local complications of femoral route coronary in-
terventions decrease with the reduction of the introducer size.Sheathless guiding
catheters developped by ASAHI* for radial approach combine an inner tubing
equivalent to standard 6 F guidings with a 4.5 F external diameter size which rep-
resents the true dimension of the arterial hole. The objective of the study was to
evaluate for the ﬁrst time the feasibility and safety of these new guidings through
femoral artery in a large variety of coronary interventions.
Methods: 303 consecutive patients (pts), 76% male,BMI:27.1 3.5 kgm2,mean
age:681.7 years,31% diabetic,excluding acute myocardial infarction with GIIb3a,-
were enrolled. PCI was performed immediately after diagnostic angiography through
4 F arterial sheath in 99 unstable patients or was progammed in 204 patients. Anti-
coagulation was obtained by injecting a mean dose of 4000860 ui heparin .
Immediately after PCI sheathless catheter was removed , manual compression was
performed and time monitored. No arterial closure devices were used.In Hospital and
30 days local complications were also evaluated.
Results: In 285 single vessel PCI pts ,due to the excellent torque of the system with
the dilator inside,only 303 sheathless catheters were utilised.In 18 pts with right and
left coronary angioplasty during the same procedure 18 sheathless catheters were
exchanged to controlateral curve catheter without bleeding. Exchange for 6 F
standard guiding catheters was necessary in only two patients. Coronary in-
terventions with 375 stents ,including 11 non protected left main stenting were
successful in 99,3% of the cases. Mean haemostasis time was shortened to 316174
seconds. 30 days minor complications included 2 small hematomas without any
transfusion and one small false aneurysm spontaneously thrombosed at day 4.
Compared to 6F procedures with closure device,in hospital cost was reduced by 80
Euros.
Conclusions: This ﬁrst clinical study shows that Sheathless “4.5F” guiding catheters
can be used succesfully through femoral artery in a large variety of patients with an
extremely low groin complication rate (1%). Direct comparison with radial approach
needs to be investigated in the future.ar Access and Intervention - Femoral (includes closure devices) B245
